1 option
Chemosensitivity testing in oncology / U. Reinhold, W. Tilgen (edss.) ; with 75 figures, some in colour, and 45 tables.
Holman Biotech Commons RC261 .R35 v.161 2003
Available
- Format:
- Book
- Series:
- Recent results in cancer research ; 161.
- Recent results in cancer research ; 161
- Language:
- English
- Subjects (All):
- Cancer--Chemotherapy--Congresses.
- Cancer.
- Cancer--Chemotherapy.
- Drug resistance in cancer cells--Congresses.
- Drug resistance in cancer cells.
- Antineoplastic agents--Testing--Congresses.
- Antineoplastic agents.
- Drug Resistance, Neoplasm.
- Antineoplastic agents--Testing.
- Antineoplastic Agents--therapeutic use.
- Drug Therapy--methods.
- Medical Subjects:
- Drug Resistance, Neoplasm.
- Antineoplastic Agents--therapeutic use.
- Drug Therapy--methods.
- Genre:
- Conference papers and proceedings.
- Physical Description:
- x, 245 pages : illustrations (some color) ; 24 cm.
- Place of Publication:
- Berlin ; New York : Springer, [2003]
- Summary:
- The last decade has seen a renaissance of the concept of individualized chemotherapy in oncology, markedly stimulated by the development of new in vitro chemosensitivity assays. The clinical utility of drug response assays has been evaluated in clinical trials and the results suggest that assay-assisted therapy selection may improve survival as well as economic outcomes. This volume comprises the proceedings of the first Symposium of the International Society for Chemosensitivity Testing in Oncology, ISCO-1, held in Homburg/Saar, Germany, in September 2001. The topics include: new in vitro drug-testing methods, tumor chemosensitivity assays, and the clinical relevance of assay-directed therapy.
- Notes:
- Includes bibliographical references and index.
- ISBN:
- 3540434682
- OCLC:
- 49671197
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.